Navigation Links
Cryolife Once Again Severely Maims an Innocent Knee Surgery Patient
Date:1/11/2008

$110,000,000.00 lawsuit filed 11 Dec. 2008

ATLANTA, Jan. 11 /PRNewswire-USNewswire/ -- Cryolife, Inc., (NYSE: CRY) the country's largest distributor of cadaver tissue has once again severely maimed an elective knee surgery patient, Michael Hohenbery, with a contaminated infected knee tissue implant. Shockingly the same deadly organism that devastated Mr. Hohenbery took the life of young Brian Lykins of Minnesota in 2001.

The Lykins' death, another of the Keenan Law Firm's clients, first alerted the nation of the unregulated cadaver tissue billion dollar industry. Brian's death led the FDA shutdown in 2002 of Cryolife's tissue business and the passage of 900 plus pages of safety regulations which at the time of passage were insufficient and created large loopholes.

The FDA eventually after a year in mid 2003 permitted Cryolife to resume distribution of cadaver tissue but yet less than 30 days later a teenager from Denver was catastrophically infected by diseased knee cadaver tissue. Over the years many lawsuits have been prosecuted across the United Stated, Europe, and other countries concerning unsafe cadaver processing practices.

The recent victim Michael Hohenbery a farm equipment mechanic from downstate Illinois can no longer work and will be on mega antibiotics and pain medications the rest of his life. His suit will be filed Friday in Cobb County the location of Cryolife.

The Hohenbery case once again proves the unsafe and dangerous practices of Cryolife and the ineffectiveness of the safety regulations. While all states require licensure, testing and health certificates for barbers, nail salon technicians, and masseuses, there are no regulations regarding the qualifications of anyone handling and processing cadaver tissue.

"With over one million operations a year using cadaver tissues, how many more people will die or be seriously injured from dangerous unsafe practices of Cryolife. This travesty must stop," said Don Keenan attorney for Michael Hohenbery.

Don Keenan is available for comment 24/7.


'/>"/>
SOURCE KEENAN LAW FIRM/KEENAN'S KIDS FOUNDATION
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. CryoLife Names Philip Theodore as Vice President, General Counsel
2. CryoLife to Present at Bear Stearns Healthcare and First Albany Capitals Regenerative Technologies Conferences in New York
3. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
4. CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million
5. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
6. CryoLife to Present at 19th Annual Piper Jaffray Health Care Conference in New York
7. CryoLife to Present at OneMedPlace Finance Forum
8. CryoLife Announces Record Preservation Services and Product Revenues for 2007
9. CryoLife Responds to Inaccurate Assertions from Plaintiffs Attorney
10. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
11. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):